What is a Prostate Fusion Biopsy | Risks and side effects

A prostate fusion biopsy is an advanced technique used to diagnose prostate cancer more accurately. The procedure uses MRI findings to identify areas of concern before the biopsy, while ultrasound provides real-time guidance to help the urologist accurately perform the biopsy.  The approach can improve detection of clinically significant prostate cancer while supporting more informed treatment decisions.

What is a Prostate Fusion Biopsy?

A prostate fusion biopsy is a modern method of diagnosing prostate cancer. It combines two imaging technologies, magnetic resonance imaging (MRI) and real-time ultrasound, to improve the accuracy of prostate biopsies.

Before the biopsy, the patient undergoes a multiparametric MRI (mpMRI) scan, which helps identify areas of the prostate that appear suspicious for cancer. During the procedure, specialised software combines these MRI images with live ultrasound images, allowing the urologist to view both simultaneously and accurately guide the biopsy needle to the targeted area.

While the main focus is on the suspicious areas identified by the MRI, your urologist may also collect samples from other parts of the prostate to provide a more complete evaluation. This comprehensive approach helps detect clinically significant cancers while reducing the likelihood of missing suspicious areas that require further evaluation.

Why is a prostate fusion biopsy performed?

A prostate fusion biopsy is performed when there is a higher likelihood of prostate cancer and a more precise evaluation of the prostate is needed. By combining MRI findings with real-time ultrasound guidance, the procedure helps target suspicious areas that may require closer examination.

Your urologist may recommend a prostate fusion biopsy if:

• Your prostate-specific antigen (PSA) level is higher than expected.
• A digital rectal examination (DRE) reveals an abnormality in the prostate.
• An MRI scan identifies a suspicious area that requires tissue sampling.
• A previous prostate biopsy was negative, but concerns about prostate cancer remain.
• You have a low-risk prostate cancer that is being carefully monitored, and repeat biopsies are recommended to ensure the cancer has not become more aggressive. 

Compared with conventional ultrasound-guided biopsy, a fusion biopsy provides greater precision when sampling suspicious lesions. It can be particularly valuable for men with persistent clinical concerns despite an earlier negative biopsy, as it improves the likelihood of identifying clinically significant prostate cancer that may have been missed previously.

What are the side effects and risks?

A prostate fusion biopsy is generally considered a safe and well-tolerated procedure. While most patients recover without complications, mild side effects are common, and serious complications are uncommon.

After the procedure, you may experience:

• Minor bleeding: A small amount of blood from the biopsy site, in the urine, or during bowel movements may occur for a few days.
• Blood in the semen: It is normal for semen to appear discoloured after the biopsy, with a pink, reddish, or brownish tint that may persist for several weeks before gradually returning to normal. This is a temporary side effect, and it is considered the most common.
• Temporary discomfort: It is common to experience mild tenderness or soreness around the biopsy site after the procedure. These symptoms usually settle within a few days and, if necessary, your doctor may recommend suitable pain relief. 
• Difficulty passing urine: Some men may notice temporary urinary discomfort or difficulty emptying the bladder. Although uncommon, medical attention should be sought if you are unable to urinate.
• Infection: The risk of infection is low, particularly with the transperineal approach. However, fever, chills, or worsening pain after the biopsy should be reported to your healthcare provider immediately.

Some patients are concerned that a biopsy could cause prostate cancer to spread. Current clinical evidence indicates that this risk is extremely low, and prostate biopsy remains a safe and well-established method for diagnosing prostate cancer.

What are the preparations for a Prostate Fusion Biopsy

Proper preparation helps ensure the biopsy is performed safely and accurately. Before the procedure, your urologist will provide specific instructions based on your medical history and the type of biopsy being performed.

Preparation may include the following:

• Undergoing an MRI scan: A multiparametric MRI (mpMRI) is performed before the biopsy to identify suspicious areas within the prostate. During the biopsy, the MRI scan is used alongside live ultrasound images, enabling the urologist to accurately direct the biopsy needle to the areas selected for sampling. 
• Reviewing your medications: Inform your healthcare provider about all prescription medications, over-the-counter medicines, and dietary supplements you are taking. Certain medications, particularly blood thinners, may need to be adjusted before the biopsy. Always follow your doctor’s instructions.
• Taking prescribed antibiotics: Your doctor may prescribe antibiotics before the procedure to reduce the risk of infection. Take the medication exactly as directed.
• Checking for urinary infections: In some cases, a urine test may be required before the biopsy to rule out a urinary tract infection. If an infection is detected, it will usually be treated before the biopsy is scheduled.
• Preparing for sedation (if required): Some patients receive sedation to improve comfort during the procedure. If sedation is planned, you may be asked to avoid eating or drinking for several hours beforehand and arrange for someone to accompany you home after the appointment.
• Bowel preparation (if applicable): If a transrectal biopsy approach is planned, your doctor may recommend using an enema before the procedure to help prepare the rectum. This step is generally not required for a transperineal biopsy.

Following your healthcare provider’s instructions carefully can help minimise complications and ensure the procedure is completed as smoothly as possible.

Before, during, and after the procedure

Knowing what happens before, during, and after a prostate fusion biopsy can help you feel more prepared for the procedure. Although the exact process may vary depending on your healthcare provider and the biopsy approach used, most prostate fusion biopsies follow a similar sequence and are completed as an outpatient procedure.

Before

Before the biopsy begins, your healthcare team will review your medical history and medications and explain the procedure, including any potential risks and benefits. You may be asked to change into a hospital gown and sign a consent form before the biopsy.

A local anaesthetic is commonly used to numb the biopsy area and improve comfort during the procedure. In some cases, sedation may be recommended, particularly if your urologist advises it. Once you are prepared, you will be positioned on the examination table according to the biopsy approach being used, and a digital rectal examination (DRE) may be performed if required.

During 

After the biopsy area has been numbed, your urologist begins collecting tissue samples from the prostate using a specialised biopsy needle. Depending on the approach being used, the needle is inserted either through the rectum or through the skin between the scrotum and anus (the perineum).

You may notice a brief pressure, stinging, or flicking sensation as each sample is taken, but the procedure is generally well tolerated. Several tissue samples are collected for laboratory analysis to help determine whether cancer cells are present.

After the Procedure

Following the biopsy, you will be observed for a short time before being discharged. It is normal to experience mild soreness and notice small amounts of blood in the urine, semen, or at the biopsy site during the recovery period.

Most men recover quickly and can return to their usual routine within a day or two, although your doctor may advise avoiding strenuous activities for a short period. If you develop a fever, chills, difficulty passing urine, severe pain, or heavy bleeding, seek medical attention promptly, as these symptoms may indicate a complication requiring further evaluation.

What are the results?

After the biopsy, the tissue samples are sent to a laboratory, where they are examined under a microscope by a pathologist. The results are usually available within a few days to a couple of weeks, depending on the laboratory and healthcare provider.

Your biopsy results will confirm whether prostate cancer is present. If cancer is detected, the report may include important details such as:

• The type of prostate cancer: Most prostate cancers are classified as adenocarcinoma.
• The Gleason score and Grade Group: These grading systems indicate how aggressive the cancer cells appear and help guide treatment decisions.
• The extent of cancer: The report may describe how many biopsy samples contained cancer and the amount of cancer found in each sample.

Not all biopsy results indicate cancer. In some cases, the tissue may show non-cancerous conditions, such as benign prostatic enlargement (BPH) or inflammation of the prostate (prostatitis). Your urologist will review the biopsy findings with you, explain what they mean, and discuss whether any further tests, treatment, or follow-up are recommended.

Benefits of a Prostate Fusion Biopsy

Compared with a standard prostate biopsy, a prostate fusion biopsy offers several important advantages, including:

• Improved cancer detection: By combining MRI and ultrasound imaging, the procedure allows suspicious areas to be targeted more accurately, increasing the likelihood of detecting clinically significant prostate cancer.
• Better assessment of tumour aggressiveness: The targeted tissue samples help doctors determine whether a tumour is likely to grow slowly or require prompt treatment, supporting more personalised treatment decisions.
• Fewer unnecessary repeat biopsies: Because the biopsy is more precise, there is a greater chance of obtaining the required tissue samples during the first procedure, reducing the need for additional biopsies in many patients.

Know more about such prostate cancer treatments. Click here to speak to a doctor!!!

Conclusion

A prostate fusion biopsy is an advanced and reliable approach to diagnosing prostate cancer. Combining MRI and real-time ultrasound imaging, it enables more precise tissue sampling, improves the detection of clinically significant cancers, and supports informed treatment decisions. If your urologist recommends a prostate fusion biopsy, understanding the procedure and knowing what to expect can help you approach it with greater confidence and peace of mind.

FAQs